Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy
- PMID: 25332491
- PMCID: PMC4210789
- DOI: 10.1542/peds.2013-1764
Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy
Abstract
Background and objective: Bilirubin/albumin ratio (B/A) may provide a better estimate of free bilirubin than total serum bilirubin (TSB), thus improving identification of newborns at risk for bilirubin encephalopathy. The objective of the study was to identify thresholds and compare specificities of TSB and B/A in detecting patients with acute and posttreatment auditory and neurologic impairment.
Methods: A total of 193 term/near-term infants, admitted for severe jaundice to Cairo University Children's Hospital, were evaluated for neurologic status and auditory impairment (automated auditory brainstem response), both at admission and posttreatment by investigators blinded to laboratory results. The relationships of TSB and B/A to advancing stages of neurotoxicity were compared by using receiver operating characteristic curves.
Results: TSB and B/A ranged from 17 to 61 mg/dL and 5.4 to 21.0 mg/g, respectively; 58 (30%) of 193 subjects developed acute bilirubin encephalopathy, leading to kernicterus in 35 infants (13 lethal). Auditory impairment was identified in 86 (49%) of 173 infants at admission and in 22 of 128 at follow-up. In the absence of clinical risk factors, no residual neurologic or hearing impairment occurred unless TSB exceeded 31 mg/dl. However, transient auditory impairment occurred at lower TSB and B/A (22.9 mg/dL and 5.7 mg/g, respectively). Intervention values of TSB and B/A set at high sensitivity to detect different stages of neurotoxicity had nearly the same specificity.
Conclusions: Both TSB and B/A are strong predictors of neurotoxicity, but B/A does not improve prediction over TSB alone. Threshold values detecting all affected patients (100% sensitivity) increase with advancing severity of neurotoxicity.
Keywords: auditory impairment; automated auditory brainstem response; bilirubin-induced neurologic dysfunction; bilirubin/albumin ratio; bind score; hyperbilirubinemia; kernicterus.
Copyright © 2014 by the American Academy of Pediatrics.
Figures
References
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia . Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316 - PubMed
-
- Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics. 2006;117(2):474–485 - PubMed
-
- Ahlfors CE, Wennberg RP, Ostrow JD, Tiribelli C. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55(7):1288–1299 - PubMed
-
- Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics. 1994;93(3):488–494 - PubMed
-
- Sato Y, Morioka I, Miwa A, et al. . Is bilirubin/albumin ratio correlated with unbound bilirubin concentration? Pediatr Int. 2012;54(1):81–85 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources